FDA guidance
An Acceptable Circular of Information for the Use of Human Blood and Blood Components…
FDA guidance · Final · issued Sep 25, 2024
Key facts
| Title | An Acceptable Circular of Information for the Use of Human Blood and Blood Components: Guidance for Industry |
|---|---|
| Status | Final |
| Issue date | Sep 25, 2024 |
| Center | Center for Biologics Evaluation and Research |
| Issuing office | Center for Biologics Evaluation and Research |
| Communication type | Guidance Document |
| Regulated product | Biologics |
| Docket number | FDA-2002-D-0223 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents